Drug Safety Matters
If you like Drug Safety Matters, try…
Latest episodes
-
#48 Building a career in pharmacovigilance – Myriam Salem & Francesco Salvo
October 9, 2026 · 41 minSend us a voicemail! Pharmacovigilance specialists can have very different roles depending on their organisation and job title. With so many career paths to choose from, how do you find your place? Myriam Salem from Health Canada and…
-
#47 Viewing global pharmacovigilance through the local lens – Salvador Alvarado & Matthew Barwick
September 3, 2026 · 39 minSend us a voicemail! Global pharmacovigilance requires harmonised methods, but solutions must be tailored to the local context. We sat down with Salvador Alvarado and Matthew Barwick from Uppsala Monitoring Centre to explore how local…
-
#46 Protecting the health ecosystem – Valentina Giunchi & Joe Mitchell
June 4, 2026 · 34 minSend us a voicemail! Pharmacovigilance has traditionally focused on the patient at the receiving end of a medicine. But what happens to medicines once they leave the body? In this episode, Valentina Giunchi and Joe Mitchell unpack the…
-
#45 How to perform better disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek
March 26, 2026 · 47 minSend us a voicemail! For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the…
-
#44 Rethinking medical device safety, part 2 – Omar Aimer
February 26, 2026 · 21 minSend us a voicemail! Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar…
Show 7 more episodesShow fewer episodes
-
#43 Rethinking medical device safety, part 1 – Omar Aimer
January 28, 2026 · 22 minSend us a voicemail! Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can leave patients vulnerable. In this two-part episode…
-
#42 Unpacking the WHO Global Smart Pharmacovigilance Strategy – Shanthi Pal
December 16, 2025 · 18 minSend us a voicemail! This special episode was recorded just before the 43rd Annual Meeting of the WHO Programme for International Drug Monitoring wrapped up in Cairo, Egypt. Held from 27 to 29 October 2025, the meeting brought together…
-
#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén
November 21, 2025 · 29 minSend us a voicemail! Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also…
-
#40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén
October 17, 2025 · 29 minSend us a voicemail! Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities, but they…
-
#39 Putting children first on Patient Safety Day – Angela Caro-Rojas
August 29, 2025 · 26 minSend us a voicemail! Children deserve the safest possible healthcare, yet they remain one of the most vulnerable patient populations when it comes to medicines safety. Ahead of World Patient Safety Day on 17 September, we discuss…
-
#38 Patient perspectives in PV: a fireside chat at the ISoP mid-year symposium
June 19, 2025 · 35 minSend us a voicemail! This special episode was recorded at the mid-year symposium of the International Society of Pharmacovigilance (ISoP), 14–15 May 2025. Held in Uppsala, Sweden, the theme of the symposium was Improving information…
-
#37 Beyond numbers: quality in ADR reporting – Henry Zakumumpa
May 28, 2025 · 39 minSend us a voicemail! Spontaneous adverse event reporting from healthcare professionals and patients is a cornerstone in pharmacovigilance systems. Unfortunately, it is a well-known issue that only a fraction of events is reported. To…